Mark Elliott Boulding Sells 22,655 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) VP Mark Elliott Boulding sold 22,655 shares of the firm's stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $65.82, for a total value of $1,491,152.10. Following the transaction, the vice president directly owned 103,901 shares of the company's stock, valued at $6,838,763.82. The trade was a 17.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
NASDAQ:PTCT